Subscribe To
Can this new drug boost pfizer's stock?
Zavzpret is a nasal spray for treating acute migraine in adults. It could net the drug giant more than ...
March 25, 2023, 9:45 am
Bioporto a/s to host annual earnings webcast and analyst call
COPENHAGEN, DENMARK and BOSTON, MA, USA, March 23, 2023, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics ...
March 23, 2023, 2:34 pm
Sanofi's blockbuster dupixent drug clears major trial
French pharma multinational Sanofi's Dupixent drug has achieved impressive results in a late-stage trial to treat chronic obstructive pulmonary diseas...
March 23, 2023, 10:43 am
Select medical's (sem) orlando facility to boost post-acute care
Select Medical (SEM) aims to address the post-acute care demand in the Central Florida region through t...
March 21, 2023, 1:00 pm
Diamedica therapeutics to report fourth quarter 2023 financial results and provide a business update march 29, 2023
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing r...
March 20, 2023, 4:17 pm
5 hmo stocks to watch despite elevated tech costs, nursing shortage
Improved premiums cropping from a solid customer base might aid the Medical-HMO industry. However, an escalating expense level and an ...
March 17, 2023, 1:03 pm
Royalty pharma raises fy2023 guidance after $475m pfizer milestone payment
Royalty Pharma plc announced that it is raising its full year 2023 Adjusted Cash Receipts (non-GAAP) guidance to between $2.85 billion and $2.95 bill...
March 15, 2023, 11:42 am
Pfizer wins fda approval for its migraine nasal spray
Pfizer Inc. PFE, -1.65% said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first a...
March 10, 2023, 6:54 am
Mesoblast's (meso) gvhd drug bla gets fda priority tag, stock up
Mesoblast (MESO) announces the FDA acceptance for review of the resubmitted biological license application for remestemcel-L for the treatment of chil...
March 9, 2023, 8:24 am
Bionomics reports promising full results analysis from prevail phase 2 study of bnc210 social anxiety disorder (sad)
Both doses of BNC210 as an acute treatment resulted in reductions in anxiety across multiple phases of ...
March 9, 2023, 12:00 am
Wound care market size is estimated to be valued at usd 30.2 billion by 2032, at a cagr of 5.2%
According to Market.us, the estimated value of the global wound care market in terms of revenue was US$ 18.4 billion in 2022 and is anticipated to inc...
March 6, 2023, 2:35 pm
Amarin announces new reduce-it® data at acc.23/wcc showing benefit of vascepa®/vazkepa® (icosapent ethyl) in high-risk patients with a recent acute coronary syndrome event
–Post-Hoc Analysis Shows IPE Significantly Reduced Risk of First, Total Ischemic Events by 37% and 36% Respectively in Patients with Recent ACS With...
March 5, 2023, 3:21 pm
Cuba’s president meets ceo of russia’s rosneft amid fuel shortage
HAVANA (Reuters) – Russian oil firm Rosneft’s CEO Igor Sechin met with Cuba’s President Miguel Diaz-Canel late on Saturday, the island’s leade...
March 5, 2023, 2:36 pm
Fed “acutely aware” of trouble inflation is causing – report
By Howard Schneider WASHINGTON (Reuters) – The U.S. Federal Reserve is “acutely aware” of the cha...
March 3, 2023, 4:21 pm
Qantas to create thousands of new jobs as air industry moves 'from recovery to growth'
Qantas Airways (ASX:QAN) said it expects to hire 8,500 staff over the next decade as the airline industry "moves from recovery to growth". Australia's...
March 3, 2023, 3:34 am
Poolbeg pharma hails flu asset as a potential blockbuster after encouraging results
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) described its lead asset as a potential ‘blockbuster' after it announced promising results from its bacte...
March 2, 2023, 2:39 am
Universal health (uhs) to post q4 earnings: what to expect
Universal Health's (UHS) fourth-quarter results are likely to reflect an increase in same facility adjusted admissions in ...
February 22, 2023, 12:48 pm
Seastar medical to hold business update conference call on february 15, 2023
DENVER, Feb. 14, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical (Nasdaq: ICU), a medical technology company developing proprietary solutions to reduce the c...
February 14, 2023, 4:05 pm
Scilex holding company, a majority-owned subsidiary of sorrento therapeutics, inc., acquires rights to fda-approved elyxyb™ in the u.s. and canada for the acute treatment of migraine
ELYXYBTM is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute ...
February 12, 2023, 11:48 pm
Gilead (gild) kite reports positive data on car t-cell therapy
Gilead (GILD) reports positive long-term results from the phase I/II study on Tecartus (brexucabtagene autoleucel) for ...
February 10, 2023, 12:48 pm